Vanguard Asset Management
TYRA icon

Vanguard Asset Management’s Tyra Biosciences TYRA Stock Holding History

Vanguard Asset Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$494K Buy
15,479
+6,488
+72% +$215K ﹤0.01% 2191
2026
Q1 		$344K Buy
+8,991
New +$291K ﹤0.01% 2253

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Vanguard Asset Management's TYRA Position: Q2 2026 in Review

Vanguard Asset Management increased its Tyra Biosciences (TYRA) stake by 72% in Q2 2026, buying an estimated $215K and bringing the position to 15,479 shares worth $494K. The position accounts for ﹤0.01% of the portfolio, ranked #2191.

Vanguard Asset Management first reported a position in TYRA in Q1 2026 and has held it in 2 quarters since. 155 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Vanguard Asset Management held 15,479 shares of Tyra Biosciences worth $494K as of Q2 2026.
  • Vanguard Asset Management bought 6,488 Tyra Biosciences shares in Q2 2026, an estimated $215K.
  • Tyra Biosciences made up ﹤0.01% of Vanguard Asset Management's portfolio in Q2 2026, its #2191 holding.
  • Vanguard Asset Management first reported a position in Tyra Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 155 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.